Bristol Myers Squibb CEO describes new drug for treating schizophrenia

Written on 01/14/2025

Bristol Myers Squibb CEO Chris Boerner described Cobenfy, a new drug to treat schizophrenia and may also help with bipolar disorder and Alzheimer's disease.
Read full article